Table 2: Comparison of patients characteristics and outcomes based on trend of Nephrocheck™ values.
| NC ≥ 0.3 increasing trend | NC ≥ 0.3 decreasing trend | P value | |
| Number, n | 6 (54.5) | 5 (45.4) | |
| Age, years, n (± SD) | 59.5 (23.2) | 61.6 (6.6) | 0.85 |
| Sex; n (%) | 4 (66.7) | 0 | 0.03 |
| SOFA, n (± SD) | 7.5 (5) | 7.2 (4) | 0.92 |
| AKI, n (%) | 6 (100) | 0 | < 0.01 |
| Nephrocheck day 1, n (± SD) | 0.78 (0.5) | 0.75 (0.4) | 0.9 |
| Creatinine day 1, n (± SD) | 1 (0.3) | 0.86 (0.3) | 0.49 |
| Creatinine day 2, n (± SD) | 1.4 (0.7) | 0.8 (0.3) | 0.12 |
| ACE stopped, n (%) | 1 (100) | 1 (100) | - |
| Contrast use, n (%) | 0 | 1 (20) | 0.29 |
| NSAID stopped, n (%) | 1 (100) | 1 (100) | - |
| Hypotension/24 hours, n (%) | 3 (50) | 2 (20) | 0.33 |
| RRT, n (%) | 1 (16.7) | 0 | 0.34 |
| BP monitoring, n (%) | 4 (66.7) | 1 (25) | 0.20 |
| Vasopressors, n (%) | 4 (66.7) | 2 (40) | 0.40 |
| Outcomes | |||
| ICU length of stay, n (± SD) | 10.5 (5.3) | 7.8 (4.3) | 0.38 |
| Hospital length of stay, n (± SD) | 10.8 (5.3) | 14 (7) | 0.41 |